# Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, Division 2.3: Quality overall summary

Extent: E+W+S+N.I.

A review of the information related to the chemical, pharmaceutical and biological data shall be provided in a quality overall summary.
Key critical parameters and issues related to quality aspects shall be emphasised as well as justification in cases where the relevant guidelines are not followed. This document shall follow the scope and outline of the corresponding detailed data presented in Module 3.

---
Source: https://www.legislation.gov.uk/eudr/2001/83/annex/I/part/I/division/2/division/2.3 (the official version)
Page: https://openlegislation.uk/eu-directive-2001-83/annex-I/part-I/division-2/division-2.3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.